Denovo Biopharma LLC

Denovo Biopharma is a biopharmaceutical technology company that develops new drugs using a fast and effective model. Its clinical center is located in Beijing, and it has a wholly owned subsidiary in San Diego, California, United States. The company in-licenses new drugs from international pharmaceutical companies that have completed Phase II and III trials demonstrating safety and efficacy in some patients, and uses its proprietary biomarker platform technology to identify biomarkers in residual clinical samples that can predict drug efficacy. By using these newly discovered biomarkers as companion diagnostics to screen patients, Denovo Biopharma can re-conduct clinical trials in sensitive patients, thereby optimizing efficacy, safety, and tolerability and increasing the success rate of new drug development.

Denovo Biopharma is a biopharmaceutical technology company that develops new drugs using a fast and effective model. Its clinical center is located in Beijing, and it has a wholly owned subsidiary in San Diego, California, United States. The company in-licenses new drugs from international pharmaceutical companies that have completed Phase II and III trials demonstrating safety and efficacy in some patients, and uses its proprietary biomarker platform technology to identify biomarkers in residual clinical samples that can predict drug efficacy. By using these newly discovered biomarkers as companion diagnostics to screen patients, Denovo Biopharma can re-conduct clinical trials in sensitive patients, thereby optimizing efficacy, safety, and tolerability and increasing the success rate of new drug development.

Precision medicine-based new drug development

1. 1Denovo Biopharma Homepagedenovobiopharma.com
2. 2Denovo Biopharma LLC (United States)wikidata.org